Diopsys, Inc. Launches New Website for Doctors and Patients, www.Diopsys.com
PINE BROOK, N.J., May 12, 2011 /PRNewswire/ -- Diopsys, Inc. launched its new website – www.diopsys.com - that showcases the company's growing product line and vision for the future. The new website features expanded product information, educational resources for physicians and patients, as well as improved navigation and search capabilities. The re-designed site was initiated to address the growing need of customers and patients to have access to the most up-to-date clinical information.
The site's new homepage has a clean, clear design that enables visitors to quickly find the section of the site that most applies to them. The "News and Events" section gives visitors a quick look at what is going on with Diopsys' core technology, Visual Evoked Potential (VEP), the meetings Diopsys is attending, and current vision testing news. "We wanted to create a more accessible, user-friendly site for customers and patients to find the information they were looking for quickly, but also introduce them to additional knowledge on our vision testing technology," says Caitlin Ryan-Wise, Marketing Manager for Diopsys.
One of the most clinically beneficial sections of Diopsys.com is the "Case Studies" section. Optometrists, Ophthalmologists and Pediatricians each have their own area to review patient case studies that their peers have contributed. This gives physicians a chance to communicate with one another on how they are using Diopsys VEP vision testing systems to enhance their patient care.
"Additionally," Ryan-Wise says, "with the most recent launch of the Diopsys® NOVA-DN VEP Vision Testing System for optic nerve disorders including glaucoma, we have had a significant increase in optometrists and ophthalmologists looking for information on our products. We felt now was a great time to re-vamp the site for prospective customers and investors."
Diopsys, Inc. (http://www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care. The company specializes in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment. Diopsys has developed and markets the patented Enfant® Pediatric Vision Testing System, a device used by pediatricians to test for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys® NOVA-DT (Diagnostic & Tracking), Diopsys® NOVA-TR (Transient Response) and Diopsys® NOVA-DN (Diseases of the Optic Nerve) Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.
SOURCE Diopsys, Inc.